Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Dermatology
»
Psoriasis
18. November 2025
Search
medline.ch
Psoriasis
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 1344
Articles 1 - 20 / 26861
Ex Vivo Confocal Laser Scanning Microscopy for Real-Time Pattern and Single-Cell Analysis in Inflammatory Skin Diseases.
Exp Dermatol
Hartmann D, Stärr L, Maurer M, Stohldreier Y, Buttgereit L, Swarlik A, Sattler EC, French LE, Deußing M.
PMID: 41250583 [PubMed - indexed for MEDLINE]
Real-world evidence for repurposing hydralazine as a potential epigenetic modulator for psoriasis: a 16-year retrospective nationwide cohort study.
J Transl Med
Wu SE, Wang WM, Hung CT, Chung CH, Chien WC, Yang BH.
PMID: 41250209 [PubMed - in process]
Comparative efficacy and safety of oral versus subcutaneous methotrexate in the treatment of psoriasis: a systematic review, pairwise and network meta-analysis with CINeMA and GRADE assessment.
Inflammopharmacology
Alhamwi N, Saleh AO, Hammadeh BM, Aldeeb OM, Shawwa A, Lafi L, Elkadri L, Mohsen A, Mansour NJ, Rizik A, Al Halasa Z, Aljarrah A.
PMID: 41249611 [PubMed - as supplied by publisher]
Systemic therapies for psoriatic disease and serious adverse events in older adults: a population-based cohort study.
J Invest Dermatol
Drucker AM, Sutradhar R, Ling V, Eder L, Gomes T, Fralick M, Iskandar RJ, Li P, MacDougall S, Manolson M, Rochon PA, Tadrous M.
PMID: 41248822 [PubMed - as supplied by publisher]
Efficacy and Safety of Methotrexate Administered by Oral and Subcutaneous Routes in Patients with Severe Psoriasis.
J Coll Physicians Surg Pak
Amin M, Farhat K, Akhtar A, Malik SS.
PMID: 41247674 [PubMed - indexed for MEDLINE]
The risk and prevalence of hepatic diseases in psoriasis: A systematic review and meta-analysis.
J Eur Acad Dermatol Venereol
Abdi P, Andrade LF, Emam S, Gniadecki R.
PMID: 41246965 [PubMed - as supplied by publisher]
A Double-Layer Microneedle Patch Containing Methylprednisolone and Upadacitinib-Loaded Mesoporous Silica Nanocomposites for Psoriasis Treatment.
Macromol Biosci
Li D, Wang T, Liu Y, Bi H, Xu X, Wang H, Jin Q, Chen S, Lyu L, Shi J.
PMID: 41243171 [PubMed - as supplied by publisher]
Long-term safety and efficacy of secukinumab in paediatric severe plaque psoriasis: 236-week, Phase 3 trial results.
J Eur Acad Dermatol Venereol
Kaszuba A, Papanastasiou P, Krasowska D, De Lucas Laguna R, Ziv M, Ravichandran S, Bansal A, Dahale SS, Martin R, Paguet B, Magnolo N, Kingo K.
PMID: 41239909 [PubMed - as supplied by publisher]
Efficacy of secukinumab in pediatric patients with moderate to severe plaque psoriasis: A randomized study.
Medicine (Baltimore)
Zhang Y, Lu X, Zhou Y, Lei L, Wang L, Liang N, Li C.
PMID: 41239632 [PubMed - indexed for MEDLINE]
Psoriasis and Alopecia: Unveiling the Links.
Dermatol Pract Concept
Pourani MR, Khajeamiri Y, Abdollahimajd F, Zargari O.
PMID: 41236270 [PubMed]
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study.
Dermatol Pract Concept
Di Cesare A, Rosi E, Trovato E, Pescitelli L, Panduri S, Margiotta FM, Michelucci A, Capalbo E, Dragotto M, Magnano M, Rossari S, Savarese I, Buggiani G, Milanesi N, Lorenzoni E, Ricceri F, Romanelli M, Rubegni P, Pimpinelli N, Prignano F.
PMID: 41236233 [PubMed]
Switching within the class of IL-23 inhibitors for the treatment of psoriasis: A systematic review.
J Eur Acad Dermatol Venereol
Koumprentziotis IA, Stefanaki I, Stratigos A, Nicolaidou E.
PMID: 41235583 [PubMed - as supplied by publisher]
Pyzchiva (ustekinumab-ttwe): A New Biosimilar for Psoriasis.
Ann Pharmacother
Lindecker B, Giuliano C, Kale-Pradhan PB.
PMID: 41235578 [PubMed - as supplied by publisher]
Efficacy and safety of biologics in erythrodermic psoriasis: a systematic review and single-arm meta-analysis.
Front Immunol
Gao L, Shen L, Yan H, Liu X, Wang Y, Li X.
PMID: 41235248 [PubMed - indexed for MEDLINE]
Erythroderma and Bullae in a Psoriatic Patient: Navigating Diagnostic Bias.
Cureus
Nadelmann JR, Nadelmann ER, Halverstam C, Wu B.
PMID: 41234967 [PubMed]
Burden of disease and treatment patterns for psoriatic arthritis in Finland: a nationwide real-world evidence study.
Scand J Rheumatol
Ukkola-Vuoti L, Klåvus A, Toppila I, Elo P, Veijalainen L, Nordström D.
PMID: 41231852 [PubMed - as supplied by publisher]
Upadacitinib in psoriatic arthritis with prior TNF-inhibitor failure: a 56-week real-world study.
Clin Exp Rheumatol
Bakay U, Izci Duran T, Karstarli Bakay OS.
PMID: 41231514 [PubMed - as supplied by publisher]
A prospective, observational study on the epidemiology, disease characteristics and treatment outcomes for generalized pustular psoriasis in India.
Clin Exp Dermatol
Dogra S, Sharma A, Narang T, Handa S.
PMID: 41229319 [PubMed - as supplied by publisher]
One Step Closer to Conversational Medical Records: ChatGPT Parses Psoriasis Treatments from EMRs.
J Clin Med
Shapiro J, Atlas M, Baum S, Pavlotsky F, Barzilai A, Gershon R, Gleicher R, Cohen I.
PMID: 41227241 [PubMed]
Blood-Count-Derived Inflammatory Biomarkers and Characterization of Super-Responder Profile in Psoriatic Patients Receiving Biological Treatment: A Single-Center Study.
Int J Mol Sci
Ho, Zajdel R, .
PMID: 41226807 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 26861
Page 1 of 1344
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy